USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 182 filers reported holding USANA HEALTH SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,105,502 | +34.5% | 18,862 | +44.7% | 0.00% | +100.0% |
| Q2 2023 | $821,916 | +40.0% | 13,038 | +39.7% | 0.00% | 0.0% |
| Q1 2023 | $587,046 | -17.9% | 9,333 | -30.6% | 0.00% | 0.0% |
| Q4 2022 | $715,274 | -24.6% | 13,445 | -20.6% | 0.00% | -50.0% |
| Q3 2022 | $949,000 | -17.9% | 16,938 | +5.9% | 0.00% | +100.0% |
| Q2 2022 | $1,156,000 | -8.8% | 15,987 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $1,267,000 | +2.3% | 15,938 | +30.1% | 0.00% | 0.0% |
| Q4 2021 | $1,239,000 | +37.2% | 12,249 | +25.0% | 0.00% | 0.0% |
| Q3 2021 | $903,000 | +46.8% | 9,797 | +63.3% | 0.00% | 0.0% |
| Q2 2021 | $615,000 | +6.6% | 6,001 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $577,000 | -43.0% | 5,908 | -55.0% | 0.00% | 0.0% |
| Q4 2020 | $1,013,000 | +38.4% | 13,141 | +32.2% | 0.00% | 0.0% |
| Q3 2020 | $732,000 | +69.1% | 9,943 | +68.7% | 0.00% | 0.0% |
| Q2 2020 | $433,000 | -51.7% | 5,893 | -44.9% | 0.00% | 0.0% |
| Q1 2019 | $897,000 | -25.9% | 10,701 | +4.0% | 0.00% | 0.0% |
| Q4 2018 | $1,211,000 | +1.1% | 10,285 | +3.5% | 0.00% | 0.0% |
| Q3 2018 | $1,198,000 | -1.2% | 9,935 | -5.6% | 0.00% | 0.0% |
| Q2 2018 | $1,213,000 | +20.0% | 10,520 | -10.6% | 0.00% | 0.0% |
| Q1 2018 | $1,011,000 | +19.5% | 11,765 | +2.9% | 0.00% | 0.0% |
| Q4 2017 | $846,000 | +28.4% | 11,430 | +0.0% | 0.00% | 0.0% |
| Q3 2017 | $659,000 | -2.1% | 11,425 | +8.8% | 0.00% | 0.0% |
| Q2 2017 | $673,000 | +17.7% | 10,505 | +5.7% | 0.00% | 0.0% |
| Q1 2017 | $572,000 | +7.5% | 9,937 | +14.4% | 0.00% | – |
| Q4 2016 | $532,000 | -78.4% | 8,686 | -51.2% | 0.00% | -100.0% |
| Q3 2016 | $2,459,000 | -42.4% | 17,801 | -53.5% | 0.00% | -60.0% |
| Q2 2016 | $4,266,000 | -10.7% | 38,279 | -2.7% | 0.01% | 0.0% |
| Q1 2016 | $4,775,000 | -26.6% | 39,323 | -22.6% | 0.01% | -28.6% |
| Q4 2015 | $6,502,000 | +0.8% | 50,823 | +5.6% | 0.01% | -12.5% |
| Q3 2015 | $6,452,000 | +25.8% | 48,135 | +28.3% | 0.01% | +60.0% |
| Q2 2015 | $5,127,000 | +21.1% | 37,512 | -1.6% | 0.01% | 0.0% |
| Q1 2015 | $4,235,000 | +5.8% | 38,112 | -2.3% | 0.01% | +25.0% |
| Q4 2014 | $4,001,000 | +36.2% | 39,002 | -2.2% | 0.00% | 0.0% |
| Q3 2014 | $2,938,000 | -17.2% | 39,881 | -12.2% | 0.00% | 0.0% |
| Q2 2014 | $3,550,000 | +80.8% | 45,432 | +74.3% | 0.00% | +100.0% |
| Q1 2014 | $1,963,000 | +44.0% | 26,058 | +44.5% | 0.00% | 0.0% |
| Q4 2013 | $1,363,000 | +43.3% | 18,038 | +64.6% | 0.00% | +100.0% |
| Q3 2013 | $951,000 | -75.8% | 10,956 | -79.8% | 0.00% | -83.3% |
| Q2 2013 | $3,927,000 | – | 54,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |